This is not the most recent version of the article. View current version (7 JUL 2010)

Intervention Review

Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes

  1. Johnny Beney2,
  2. Lisa Bero1,*,
  3. Christine M Bond3

Editorial Group: Cochrane Effective Practice and Organisation of Care Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 17 JAN 2000

DOI: 10.1002/14651858.CD000336

How to Cite

Beney J, Bero L, Bond CM. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD000336. DOI: 10.1002/14651858.CD000336.

Author Information

  1. 1

    University of California San Francisco, Professor of Clinical Pharmacy & Health Policy, San Francisco, California, USA

  2. 2

    Institut Central des Hopitaux Valaisans, Pharmacy, Sion, Switzerland

  3. 3

    University of Aberdeen, Department of General Practice and Primary Care, Aberdeen, UK

*Lisa Bero, Professor of Clinical Pharmacy & Health Policy, University of California San Francisco, Suite 420, Box 0613, 3333 California Street, San Francisco, California, 94143-0613, USA. berol@pharmacy.ucsf.edu.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

This is not the most recent version of the article.View current version (07 Jul 2010)

 

Abstract

  1. Top of page
  2. Abstract
  3. Plain language summary

Background

In recent years pharmacists' roles have expanded from packaging and dispensing medications to working with other health care professionals and the public.

Objectives

To examine the effect of expanding outpatient pharmacists' roles on health services utilisation, costs, and patient outcomes.

Search strategy

We searched the Cochrane Effective Practice and Organisation of Care Group specialised register, MEDLINE, EMBASE, Pharmline, and International Pharmaceutical Abstracts (January 1966 to March 1999), the published abstracts of three meetings, hand searched five journals and two bibliographies, and reference lists of articles.

Selection criteria

Randomised trials, controlled clinical trials, controlled before and after studies and interrupted time series analyses comparing 1. Pharmacist services targeted at patients versus services delivered by other health professionals; 2. Pharmacist services targeted at patients versus the delivery of no comparable service; 3. Pharmacist services targeted at health professionals versus services delivered by other health professionals; 4. Pharmacist services targeted at health professionals versus the delivery of no comparable service.

Data collection and analysis

Two reviewers independently extracted data and assessed study quality.

Main results

Twenty-five studies were included involving more than 40 pharmacists and 16,000 patients. For comparison 1 (one study), scheduled service utilisation was slightly increased, whereas hospital admissions and emergency room admissions were decreased. For comparison 2, pharmacist services decreased the use of non-scheduled health services, the number of specialty physician visits or the number and costs of drugs, compared to control patients (six studies). Improvements in the targeted patient condition were reported in 10 of 13 studies that measured patient outcomes but patients' quality of life did not seem to change. For comparison 3 (one study), the intervention delivered by the pharmacist was less successful than that delivered by physician counsellors in decreasing inappropriate prescribing. For comparison 4, all studies demonstrated that pharmacist interventions produced the intended effects on physicians prescribing practices. The one study measuring patient outcomes was unable to show a difference in patients' quality of life.

Authors' conclusions

Only two studies compared pharmacist services with other health professional services. Both had some bias and did not allow us to draw conclusions about comparisons 1 and 3. The other studies supported the expanded roles of pharmacists in patient counselling and physician education. However, doubts about the generalisability of the studies, the poorly defined interventions, and the lack of cost assessments and patient outcome data, indicate that more rigorous research is needed to document the effects of outpatient pharmacist interventions.

 

Plain language summary

  1. Top of page
  2. Abstract
  3. Plain language summary

There is some evidence to support an expansion of the pharmacist's role in health management and counselling

The role of pharmacists in the community has been expanding beyond dispensing medications. It can now involve identifying, preventing, and resolving drug-related problems, as well as encouraging proper use of medications and general health promotion and education. The review found that the question of whether pharmacists can manage drug therapy as well as physicians remains unanswered due to a shortage of studies. There is some evidence from trials in the United States that counselling by pharmacists directed towards people with diabetes or hypertension improves their outcomes.